Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo ...

A phase 3 trial for myelofibrosis found that adding pelebresib to ruxolitinib was more effective than ruxolitinib alone and did not significantly increase side effects.

MSK researchers shed new light on G-quadruplexes, a type of secondary DNA structure that has attracted attention as a ...

The main symptoms of measles are fever, cough, runny nose, rash, and red watery eyes. But if you have a weakened immune system, you might not have a fever or only have a mild one. The rash can also be ...

Research at MSK Our research impact Research topics Core facilities & resources ...